Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A mixed-method study to inform the development of long-acting injectable TB treatments.

IJTLD open·2026
Same author

Comparison of methods for sampling and detection of carbapenemase-producing organisms in clinical handwash basin drains in health care.

The Journal of hospital infection·2024
Same author

The association of body mass index and odds of type 2 diabetes mellitus varies by race/ethnicity.

Public health·2023
Same author

Difficulty with Oral Health Complications in Adolescents with Developmental Disability and Obesity.

JDR clinical and translational research·2022
Same author

Corrigendum to "Paternal cannabis extract exposure in rats: Preconception timing effects on neurobehavioral effects in offspring" [Neurotoxicology 81 (2020) 180-188].

Neurotoxicology·2021
Same author

Network meta-analysis comparing techniques and outcomes of stump closure after distal pancreatectomy.

The British journal of surgery·2019

Related Experiment Video

Updated: May 25, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

Cyclic nucleotide phosphodiesterase assay technology.

S J MacKenzie1, S F Hastings, C Wells

  • 1Scottish Biomedical, Glasgow, Scotland, United Kingdom.

Current Protocols in Pharmacology
|February 2, 2012
PubMed
Summary
This summary is machine-generated.

Phosphodiesterases (PDEs) are key drug targets involved in disease pathways. We developed and validated high-throughput screening assays to characterize PDE inhibitors and their kinetic parameters for drug discovery.

More Related Videos

A Purification and In Vitro Activity Assay for a (p)ppGpp Synthetase from Clostridium difficile
09:53

A Purification and In Vitro Activity Assay for a (p)ppGpp Synthetase from Clostridium difficile

Published on: November 3, 2018

Nonradioactive Assay to Measure Polynucleotide Phosphorylation of Small Nucleotide Substrates
06:49

Nonradioactive Assay to Measure Polynucleotide Phosphorylation of Small Nucleotide Substrates

Published on: May 8, 2020

Related Experiment Videos

Last Updated: May 25, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

A Purification and In Vitro Activity Assay for a (p)ppGpp Synthetase from Clostridium difficile
09:53

A Purification and In Vitro Activity Assay for a (p)ppGpp Synthetase from Clostridium difficile

Published on: November 3, 2018

Nonradioactive Assay to Measure Polynucleotide Phosphorylation of Small Nucleotide Substrates
06:49

Nonradioactive Assay to Measure Polynucleotide Phosphorylation of Small Nucleotide Substrates

Published on: May 8, 2020

Area of Science:

  • Biochemistry
  • Enzymology
  • Pharmacology

Background:

  • Phosphodiesterases (PDEs) are crucial enzymes regulating cellular cyclic nucleotide levels.
  • PDEs are implicated in various disease-related signaling pathways.
  • The diverse PDE family presents numerous potential drug targets due to varied tissue distribution and substrate specificities.

Purpose of the Study:

  • To describe assay development and validation procedures for phosphodiesterases (PDEs).
  • To establish a high-throughput screening (HTS) system for PDE enzymes.
  • To facilitate the characterization of PDE inhibitors through kinetic parameter determination.

Main Methods:

  • Development of robust enzyme assays for PDE activity.
  • Validation of assay performance for reliability and reproducibility.
  • Implementation of high-throughput screening methodologies.
  • Kinetic analysis to determine enzyme parameters.

Main Results:

  • Established validated assay procedures for PDE screening.
  • Demonstrated a structured approach for kinetic parameter determination.
  • Enabled efficient characterization of PDE inhibitors.

Conclusions:

  • The developed assays are suitable for high-throughput screening of phosphodiesterases.
  • This methodology aids in the characterization of potential PDE-targeted therapeutics.
  • The assays support drug discovery efforts by providing kinetic insights into PDE inhibition.